Status:
COMPLETED
Efficacy of SLN Block for Chronic Cough
Lead Sponsor:
Medical University of South Carolina
Conditions:
Cough
Superior Laryngeal Nerve Block
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
This is a research study to find out if superior laryngeal nerve blocks are an effective way to reduce cough when compared to placebo (a substance without any medical value). Eligibility for the study...
Eligibility Criteria
Inclusion
- History consistent with neurogenic cough
- Exclusion of other etiologies (see exclusion criteria)
- Age ≥ 18
Exclusion
- Current neuromodulating medication use
- Untreated other etiologies of cough:
- Current smoker Current ACE/ARB use Abnormal PFTs within 6 months Uncontrolled OSA Abnormal CXR within 6 months RSI \> 13 or RFS \>11 AND workup positive for GERD (esophagram, 24-hour pH probe, manometry, EGD)
Key Trial Info
Start Date :
July 22 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 30 2022
Estimated Enrollment :
17 Patients enrolled
Trial Details
Trial ID
NCT04421092
Start Date
July 22 2020
End Date
December 30 2022
Last Update
October 23 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of South Carolina
Charleston, South Carolina, United States, 29403